Publicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (20)

2024

  1. Clinical features of individuals with laboratory values suggestive of advanced liver fibrosis when first treated for alcohol use disorder

    Alcohol, Clinical and Experimental Research, Vol. 48, Núm. 7, pp. 1313-1321

  2. Substance use disorders and cooperative research on addictions: Spanish approach as a model

    Pharmacological Research, Vol. 206

2023

  1. Associations of hypomagnesemia in patients seeking a first treatment of alcohol use disorder

    Drug and Alcohol Dependence, Vol. 245

2022

  1. Acute stress and alcohol exposure during adolescence result in an anxious phenotype in adulthood: Role of altered glutamate/endocannabinoid transmission mechanisms

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 113

  2. Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder

    Biomedicines, Vol. 10, Núm. 5

2021

  1. Gender perspective in dual diagnosis

    Brain Sciences, Vol. 11, Núm. 8

2019

  1. Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders

    PLoS ONE, Vol. 14, Núm. 3

2018

  1. Pacientes con trastorno por uso de alcohol: resultados iniciales de un registro multicéntrico en la Red de Trastornos Adictivos-RTA. Estudio CohRTA

    Adicciones: Revista de socidrogalcohol, Vol. 30, Núm. 4, pp. 292-300

2016

  1. Can symptoms help in differential diagnosis between substance-induced vs independent psychosis in adults with a lifetime diagnosis of cocaine use disorder?

    Psychiatry Research, Vol. 242, pp. 94-100

2015

  1. Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context

    Frontiers in Cellular Neuroscience, Vol. 9

  2. Plasma Concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: Relationship to psychiatric comorbidity

    PLoS ONE, Vol. 10, Núm. 3

  3. Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: Influence of cocaine symptom severity and psychiatric co-morbidity

    Addiction Biology, Vol. 20, Núm. 4, pp. 756-772

  4. Sex differences in psychiatric comorbidity and plasma biomarkers for cocaine addiction in abstinent cocaine-addicted subjects in outpatient settings

    Frontiers in Psychiatry, Vol. 6, Núm. FEB

2014

  1. Effects of topiramate on ethanol-cocaine interactions and DNA methyltransferase gene expression in the rat prefrontal cortex

    British Journal of Pharmacology, Vol. 171, Núm. 12, pp. 3023-3036

2013

  1. Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats

    European Journal of Neuroscience, Vol. 37, Núm. 1, pp. 105-117

  2. Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: Impact of psychiatric co-morbidity

    Addiction Biology, Vol. 18, Núm. 6, pp. 955-969

2012

  1. Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoids

    PLoS ONE, Vol. 7, Núm. 5

  2. Unsaturated fatty alcohol derivatives of olive oil phenolic compounds with potential low-density lipoprotein (LDL) antioxidant and antiobesity properties

    Journal of Agricultural and Food Chemistry, Vol. 60, Núm. 4, pp. 1067-1074

2010

  1. Synthesis of fatty acid amides of catechol metabolites that exhibit antiobesity properties

    ChemMedChem, Vol. 5, Núm. 10, pp. 1781-1787

2009

  1. Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue

    PLoS ONE, Vol. 4, Núm. 9